Eastgate Biotech Corp. logo

Eastgate Biotech Corp. (ETBI)

Market Closed
5 Dec, 20:00
EXPM EXPM
$
0. 00
0
0%
$
6.17M Market Cap
- P/E Ratio
0% Div Yield
7,733,200 Volume
0 Eps
$ 0
Previous Close
Day Range
0 0
Year Range
0 0
Want to track ETBI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ETBI closed Friday higher at $0, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, ETBI stock gained 2,900%.
ETBI is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2016, missed the consensus estimates by 0%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on EXPM (USD).

ETBI Chart

Similar

Poxel S.A.
$ 0.25
0%
Somatic Systems Inc.
$ 0
0%
PharmaCom BioVet, Inc.
$ 0
0%
Medical Services International Inc.
$ 0
0%
Alternative Energy Partners, Inc.
$ 0
0%

Eastgate Biotech Corp. (ETBI) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Eastgate Biotech Corp. is listed on EXPM.

What is its stock symbol?

The ticker symbol is ETBI.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 6.17M.

Has Eastgate Biotech Corp. ever had a stock split?

No, there has never been a stock split.

Eastgate Biotech Corp. Profile

Pharmaceuticals Industry
Healthcare Sector
Rosella C. Perri CEO
EXPM Exchange
277253100 CUSIP
US Country
2 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Eastgate Biotech Corp. is a development stage company that specializes in creating novel formulations of natural compounds and pharmaceutical products. Initially founded in 1999 as Eastgate Acquisitions Corporation, the company underwent a name change in December 2014 to better reflect its focus on biotechnological advancements. Headquartered in Toronto, Canada, Eastgate Biotech Corp. is dedicated to developing a diverse range of products, from pharmaceuticals aimed at treating acute medical conditions to natural products and dietary supplements designed for everyday health support. Notably, the company has entered into a collaboration with Biotech Corp. to develop a vaccine against COVID-19, showcasing its commitment to addressing contemporary global health challenges.

Products and Services

  • Lorazepam Oral Spray: This product is being developed as an emergency treatment for acute seizures. Its oral spray formulation aims to provide a rapid and convenient administration method during critical moments.
  • Ketoconazole 2% Topical Ointment: Designed for the treatment of skin fungal infections, this ointment leverages the antifungal properties of Ketoconazole, making it suitable for managing various dermatological conditions.
  • Metformin Chewable/Sublingual Tablets: Eastgate is working on these tablets to treat type 2 diabetes, offering an innovative administration route that could potentially enhance patient compliance and absorption efficiency.
  • Natural Products and Dietary Supplements: The company is also developing a range of health-related products including:
    • E-drops Nano and PURALEN: These are self-nanoemulsifying compositions containing natural essential oils intended for oral administration, designed to enhance bioavailability and deliver natural health benefits.
    • Glucora: A soft gelatin capsule that contains Banaba extract in a self-emulsifying formulation, intended to support glycemic control when administered orally.
    • URBAN POWER: This combines Ursolic acid and Banaba extract in a self-emulsifying soft gelatin capsule for oral administration, aiming to provide various health benefits including potentially supporting weight management and metabolic health.
    • Vitamin D3 Nanoemulsion: A nanoemulsion containing cholecalciferol (Vitamin D3) designed for enhanced absorption and effectiveness in vitamin D supplementation.
    • Cleanezze: A hand sanitizer product that combines efficacy with natural oil ingredients, aimed at providing a more skin-friendly sanitizing option.

Contact Information

Address: 65 Harbour Square Suite 2203Toronto, M5J 2L4Canada
Phone: 647-692-0652